Evidence map›Paper›PMID 39802031›Full record

ArticleHeliyon2025

Transcatheter mitral valve repair with MitraClip® enabling single lung transplantation: A case report.

François M Carlier, Michel Dumonceaux, Thomas Planté-Bordeneuve, Patrick Evrard, Eric Marchand, Asmae Belhaj, Benoît Rondelet, Fabian Demeure

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

François M CarlierLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Michel DumonceauxLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Thomas Planté-BordeneuveLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Patrick EvrardLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Eric MarchandDepartment of Pneumology, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Asmae BelhajLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Benoît RondeletLung Transplant Centre, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.
Fabian DemeureDepartment of Cardiology, CHU Mont-Godinne UCL Namur, Yvoir, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-capillary hypertension resulting from mitral regurgitation is typically considered a contraindication for single lung transplantation due to heightened risks of primary graft dysfunction. This case report highlights a 66-year-old COPD patient with severe mitral regurgitation who was deemed ineligible for surgical mitral replacement. As an alternative, transcatheter mitral valve replacement was successfully performed, resulting in the normalization of pulmonary artery pressures. Consequently, the patient became eligible for single lung transplantation, which was conducted successfully in the subsequent months. Eighteen months post-lung transplantation, the patient now experiences a normal functional status and excellent lung function. In conclusion, transcatheter mitral valve replacement appears to be a safe alternative to surgery for normalizing post-capillary pulmonary hypertension in patients with chronic respiratory diseases. This approach could potentially facilitate lung transplantation (LTx) in eligible candidates.

Indexed as

Case reportLung transplantationMitral regurgitationPulmonary hypertensionTMVr

Identifiers

PMID39802031
PMCPMC11721235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.